Novartis Reveal Positive Results From Phase III Study In Liver Transplantation RTT News Novartis International AG (NVS: Quote) Monday announced positive results from the the largest Phase III study ever in liver transplantation that confirmed comparable efficacy to control and superior renal function results previously seen in 12 months. Novartis' Certican succeeds in liver transplant trial |
